|Bid||0.0000 x N/A|
|Ask||0.0000 x N/A|
|Day's range||2.9450 - 2.9980|
|52-week range||2.9450 - 2.9980|
|Beta (5Y monthly)||2.66|
|PE ratio (TTM)||N/A|
|Earnings date||02 Mar 2022 - 07 Mar 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Investors need to pay close attention to Arbutus Biopharma (ABUS) stock based on the movements in the options market lately.
We can readily understand why investors are attracted to unprofitable companies. For example, although...
Anixa Biosciences' (ANIX) potential COVID-19 compounds show effectiveness against the Omicron variant of COVID-19.